HIBERCELL

HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.

HIBERCELL

Social Links:

Industry:

Biotechnology Health Care Health Diagnostics Medical

Founded:

2019-01-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.hibercell.com

Total Employee:

11+

Status:

Active

Contact:

212-601-2800

Email Addresses:

[email protected]

Total Funding:

158.15 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins

Similar Organizations

abdera-therapeutics-logo

Abdera Therapeutics

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

rakuten-medical-logo

Rakuten Medical

Rakuten Medical is a Bio-technology Company.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

q32-bio-logo

Q32 Bio

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Current Employees Featured

alan-rigby_image

Alan Rigby
Alan Rigby Co-Founder, President & Chief Executive Officer @ HiberCell
Co-Founder, President & Chief Executive Officer

ari-nowacek_image

Ari Nowacek
Ari Nowacek Co-Founder and Chief Business Officer @ HiberCell
Co-Founder and Chief Business Officer

thomas-w-chittenden_image

Thomas W. Chittenden
Thomas W. Chittenden Chief Technology Officer @ HiberCell
Chief Technology Officer
2021-01-01

joseph-talamo_image

Joseph Talamo
Joseph Talamo Senior Vice President and Chief Financial Officer @ HiberCell
Senior Vice President and Chief Financial Officer
2020-08-01

josé-iglesias_image